(Q44556316)

4 December 2017

Factors associated with participation in screening for colorectal cancer with faecal occult blood testing (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

Lindholm E

1

1 reference

4 December 2017

Berglund B

series ordinal

2

1 reference

4 December 2017

Haglind E

series ordinal

3

1 reference

4 December 2017

Kewenter J

series ordinal

4

1 reference

4 December 2017

1 February 1995

1 reference

Scandinavian Journal of Gastroenterology

4 December 2017

1 reference

4 December 2017

30

1 reference

4 December 2017

2

1 reference

4 December 2017

171-176

1 reference

Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects

4 December 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

Haemoccult compliance rates and reasons for non-compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

Causes of Death during the First 5 Years of a Randomized Trial of Mass Screening for Colorectal Cancer with Fecal Occult Blood Test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365529509093257

10.3109/00365529509093257

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference